Global Endocrine Testing Market (E2, FSH, hCG, LH, DHEAS, Progesterone, Testosterone, TSH, Prolactin, Cortisol, Insulin Tests)- Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019

The global market for endocrine testing market was valued at USD 1,537.5 million in 2012 growing at a CAGR of 4.3% from 2013 to 2019.

 

Albany, NY -- (SBWIRE) -- 11/20/2015 -- Endocrinology, a branch of medicine deals with the study of structural and functional elements of the endocrine system. This system comprises endocrine glands (thyroid, adrenal, pituitary and others) and secretory organs (pancreas, hypothalamus) that release hormones directly into the blood stream and regulate the body functioning. Endocrine system is instrumental in regulating certain body mechanisms such as metabolism, growth and sexual development. Furthermore, endocrine system works in close co-ordination with nervous system to help body cope up with several cellular mechanisms and stress. Responses to stress, absorption of nutrients maintenance of water and electrolyte balance, injury and energy metabolism constitute the major areas of control and integration controlled by the endocrine system. There is a need for regular testing of endocrine hormone levels in the body as any deficiency or overproduction will lead to abnormal functioning of the endocrine gland thereby resulting in development of certain endocrine disorders. For instance, deficiency or overproduction of thyroid hormone results in hypothyroidism or hyperthyroidism respectively.

Complete Report with TOC @ http://www.mrrse.com/endocrine-testing-market

Endocrine testing market is studied by three major segments namely, by test, by diagnostic technologies and by end users. The test segment is further classified into 11 major hormone tests that includes estradiol (E2), Follicle Stimulating Hormone (FSH), Human Chorionic Gonadotropin (hCG), Luteinizing hormone (LH), Dehydroepiandrosterone sulfate (DHEAS), progesterone, testosterone, Thyroid Stimulating Hormone (TSH), prolactin, cortisol and insulin tests.

The market accounts for a wide range of conventional as well as rapid diagnostic kits used for detecting the deficiency (hyposecretion) or excess (hypersecretion) secretions of these hormones. The diagnostic technologies segment further describes the technological platforms used in the analysis of the specimen test sample (blood, urine, etc) and is further categorized into five major technologies, tandem mass spectrometry, immunoassay, monoclonal and polyclonal antibody, sensor and clinical chemistry technologies. The end user segment elucidates the endocrine testing market by various end users that includes hospitals, commercial laboratories, ambulatory health care centers, home based tests and physician's offices.

A detailed market analysis and forecast for each of these segments have been provided in this study, in terms of market revenue (USD million) for the period 2011 to 2019. The report also provides the compounded annual growth rate (CAGR %) for each of these segments for the forecast period from 2013 to 2019, considering 2011 and 2012 as base years.

Get Discount on this report @ http://www.mrrse.com/checkdiscount/901

On the basis of geography, the market is classified into North America, Europe, Asia-Pacific, Africa, Latin America and Rest of the World (RoW). The current and future market size in terms of revenue (USD million) and volume (number of units) for each of these regions along with CAGR have also been provided in the report, considering from 2013 to 2019 as a forecast period and, 2011 and 2012 as base years.

The market overview section of the report elucidates the major market dynamics such as drivers, restraints and opportunities that influence the current as well as future market trends of the industry. A PESTLE analysis has also been considered while estimating the market for individual geographies in order to provide current as well as future status.

Several other analytical perspectives such as Porter's Five Forces Analysis, market share analysis and market attractiveness have been described in the report in order to give a thorough analysis of the market. Also, a list of recommendations for existing as well as new entrants has also been discussed in the study which would help in decision making. The report concludes with the company profiles section including key information about the key players in the market such as financial overview, business strategies, product portfolio and recent developments. Abbott Laboratories, AB SCIEX LLC, DiaSorin S.p.A, F.Hoffmann-La Roche, Ltd., Sysmex Corporation, Thermo Fisher Scientific and Agilent Technologies are some of the key players operating in this market.

Request a Sample Copy of the Report @ http://www.mrrse.com/sample/901

About MRRSE
MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.